Adverse Outcomes and Mortality in Liver Transplant

Recruiting now · Not applicable

Conditions studied: End Stage Liver DIsease, Sarcopenia, Sarcopenic Obesity, Cirrhosis

In brief

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Key facts

Study ID

NCT05477277

Run by

Mayo Clinic

People needed

100

Starts

2022-11-02

Expected to finish

2027-12-31

Last updated by the study team

2026-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients with end-stage liver disease undergoing evaluation for liver transplantation
• Patient clinically indicated for MRI during transplant candidacy evaluation
• Adult

You may not qualify if…

• Contra indication to MRI

Where it is running

• Mayo Clinic Arizona — Phoenix, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.